首页> 外文期刊>Aesthetic surgery journal >Correction of Tear Trough Deformity With Novel Porcine Collagen Dermal Filler (Dermicol-P35)
【24h】

Correction of Tear Trough Deformity With Novel Porcine Collagen Dermal Filler (Dermicol-P35)

机译:新型猪胶原蛋白真皮填充剂(Dermicol-P35)矫正泪槽畸形

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Deformity of the tear trough region, which can occur during the aging process, can result in dark shadows under the eyes and a fatigued appearance. Augmentation of the tear trough is challenging because of the thin skin and lack of fat in the region. Adding volume to the tear trough region with a dermal filler is a nonsurgical procedure with minimal discomfort to the patient. Dermicol-P35 (Evolence; Ortho Dermatologics, Skillman, NJ) is a new, ribose crosslinked, highly purified, porcine-based collagen filler that does not require prior skin testing and has shown improved persistence compared with bovine collagen-based dermal fillers. In this article, we present the clinical outcomes of patients who have received treatment with a novel ribose crosslinked porcine collagen dermal filler for the correction of tear trough deformity.
机译:在老化过程中可能发生的泪液槽区域变形,可能导致眼睛下方的阴影和疲劳的外观。由于该区域皮肤薄且脂肪少,因此增加泪液槽具有挑战性。用皮肤填充剂增加泪液区域的体积是非手术过程,对患者的不适感最小。 Dermicol-P35(Evolence; Ortho Dermatologics,Skillman,NJ)是一种新型的,核糖交联的,高度纯化的,猪基胶原蛋白填充剂,与以前的牛胶原蛋白真皮填充剂相比,无需事先皮肤测试,并且显示出改善的持久性。在本文中,我们介绍了使用新型核糖交联猪胶原蛋白真皮填充剂治疗泪腺畸形的患者的临床结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号